Valuation: Azenta, Inc.

Market Cap 1.25B 1.1B 1.02B 941M 1.76B 121B 1.8B 12.23B 4.77B 59.13B 4.7B 4.6B 205B P/E 2026 *
-7.42x
P/E 2027 * 113x
Enterprise Value 1.25B 1.1B 1.02B 941M 1.76B 121B 1.8B 12.23B 4.77B 59.13B 4.7B 4.6B 205B EV / Sales 2026 *
2.08x
EV / Sales 2027 * 1.99x
Free-Float
76.62%
Yield 2026 *
-
Yield 2027 * -
1 day+4.20%
1 week+5.68%
Current month+10.89%
1 month+27.48%
3 months+12.70%
6 months-29.34%
Current year-14.91%
1 week 25.18
Extreme 25.18
28.34
1 month 22.22
Extreme 22.22
28.34
Current year 15.93
Extreme 15.93
41.73
1 year 15.93
Extreme 15.93
41.73
3 years 15.93
Extreme 15.93
69.16
5 years 15.93
Extreme 15.93
124.79
10 years 12.05
Extreme 12.05
124.79
Manager TitleAgeSince
Chief Executive Officer 45 2024-09-08
Director of Finance/CFO 49 2024-11-30
Chief Tech/Sci/R&D Officer - 2009-10-31
Director TitleAgeSince
Director/Board Member 64 2013-06-27
Director/Board Member 50 2020-04-02
Chairman 72 2024-01-29
Date Insider Type Main position Quantity % Market Cap.
5/18/26 Buy

Director

10,000 0.0217%
5/15/26 Tax

General Counsel

-3,621 0.0079%
4/28/26 Free

President Multiomics

17,790 0.0386%
Change 5-day change 1-year change 3-year change Capi.($)
+4.20%+5.68%-17.92%-39.63% 1.25B
+1.08%-6.74%-2.31%+10.45% 46.06B
+3.13%+5.34%+402.93%+627.64% 38.91B
+2.14%+2.95%+10.83%+67.37% 35.57B
+4.43%-1.51%+6.73%-9.13% 33.13B
+1.23%-1.99%-0.05%+30.76% 26.42B
+0.29%-2.75% - - 16.61B
+14.71%+12.62%+38.50%+145.33% 15.08B
-6.32%-4.59%+4.36%+8.22% 14.08B
+1.82%+0.19%+1.45%-29.80% 12.81B
Average +2.77%-1.74%+49.39%+90.13% 23.99B
Weighted average by Cap. +2.63%-2.45%+75.31%+132.94%

Financials

2026 *2027 *
Net sales 600M 528M 491M 451M 846M 58.15B 861M 5.87B 2.29B 28.36B 2.25B 2.21B 98.4B 630M 554M 515M 474M 888M 61.02B 904M 6.16B 2.4B 29.76B 2.37B 2.31B 103B
Net income -159M -140M -130M -120M -224M -15.41B -228M -1.56B -607M -7.52B -598M -585M -26.08B 17.3M 15.22M 14.13M 13M 24.38M 1.68B 24.82M 169M 65.93M 817M 64.95M 63.54M 2.84B
Net Debt - -
Logo Azenta, Inc.
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.
Employees
2,900
Date Price Change Volume
26-07-23 $28.30 +4.20% 607,300
26-07-22 $27.16 +2.14% 498,555
26-07-21 $26.59 +1.26% 557,152
26-07-20 $26.26 -0.11% 346,152
26-07-17 $26.29 -1.83% 407,882
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
27.16USD
Average target price
27.80USD
Spread / Average Target
+2.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AZTA Stock